Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression.
The Wnt signaling pathway is a robust regulator of skeletal homeostasis. Gain-of-function mutations promote high bone mass, whereas loss of Lrp5 or Lrp6 co-receptors decrease bone mass. Similarly, mutations in antagonists of Wnt signaling influence skeletal integrity, in an inverse relation to Lrp r...
Saved in:
| Main Authors: | Damian C Genetos, Clare E Yellowley, Gabriela G Loots |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-03-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0017772&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sclerostin
by: Stuart L. Silverman
Published: (2010-01-01) -
Osteocytic vinculin controls bone mass by modulating Mef2c-driven sclerostin expression in mice
by: Yishu Wang, et al.
Published: (2025-08-01) -
Sclerostin levels in patients with acromegaly
by: Arnika Wydra, et al.
Published: (2025-08-01) -
The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
by: Se Hwa Kim, et al.
Published: (2014-01-01) -
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition
by: Hayley M. Sabol, et al.
Published: (2025-08-01)